Item 2.02 - Results of Operations and Financial Condition: The filing reports financial results and operational performance for Intuitive Surgical, Inc. Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and exhibits related to the reported results. Filing Date: Current report filed on January 22, 2026, reporting on events as of the same date. Company…

Our analysis rates this filing CAUTIOUS. Intuitive Surgical faces an elevated concern level driven by three material developments: (1) newly quantified tariff exposure representing 1.2% of 2026 revenue with explicit warning of potential material expansion, (2) meaningful deceleration in core Da…

Concern level: HIGH (6.8/10). Key factors: New high-severity tariff risk (severity 7/10): 1.2% of 2026 revenue impact quantified with explicit warning of material additional impact if tariffs expand or change; Core business deceleration: Da Vinci procedure growth expected to slow from 18% (2025) to 13-15% (2026), representing 3-5 percentage point deceleration in flagship product; Ion system…

Notable risk changes: Tariffs now quantified as 1.2% of 2026 revenue impact with explicit warning of material additional impact if tariffs expand - this is a newly disclosed material headwind not previously disclosed with specificity; Da Vinci procedure growth deceleration from 18% (2025) to 13-15% guidance (2026) signals market maturation and potential competitive pressures in core business; Ion system placements…

The model predicts ISRG will outperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.